LSBio
LSBio
Products
Services
Research Areas
Resources
Contact Us
Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.

Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".

LSBio
2401 Fourth Avenue Suite 900
Seattle WA 98121

Phone: 866-819-4732 (Toll Free North America)
206-374-1102 (International)

Fax: 866-206-6909 (Toll Free North America)
206-577-4565 (International)

How to Buy - Details about how to buy our products.

Orders@LSBio.com - To submit a new order.

Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability, bulk quotes, proforma invoice requests, or other billing issues.

Technical.Support@LSBio.com - To request technical information requests about an LSBio product or its application.

Sales@LSBio.com - To request information about fee-for-service contract IHC studies, IHC reports, distribution agreements, or general business development.

Worldwide Distributors List - To find your local distributor if you're not within the United States.
Products
Services
Research Areas
Resources
Contact Us
S100A7 / Psoriasin Antibody (aa18‑30) IHC‑plus™ LS‑B4332
Note: This antibody replaces LS-C55334
Psoriasin antibody LS-B4332 is an unconjugated goat polyclonal antibody to human Psoriasin (S100A7). Validated for IHC, Peptide-ELISA and WB. Tested on 20 paraffin-embedded human tissues.
Catalog
Size
Price
LS-B4332-50
50 µg (0.5 mg/ml)
Unavailable

Popular S100A7 / Psoriasin Products

Anti-S100A7 antibody IHC of human skin. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B2056 concentration 10 ug/ml. This image was taken for the unmodified form of this product. Other forms have not been tested.
Species: Human
Applications: IHC, IHC - Paraffin, Western blot
Anti-S100A7 antibody IHC of human skin. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B2057 concentration 10 ug/ml.
Species: Human
Applications: IHC, IHC - Paraffin, ICC, Western blot
Western blot of recombinant S100A7 / Psoriasin.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Species: Mouse
Applications: IHC, Western blot
Western blot of recombinant S100A7 / Psoriasin.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Species: Human
Applications: IHC, Western blot

Product Description

Psoriasin antibody LS-B4332 is an unconjugated goat polyclonal antibody to human Psoriasin (S100A7). Validated for IHC, Peptide-ELISA and WB. Tested on 20 paraffin-embedded human tissues.
About S100A7 / Psoriasin
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. P31151 NM_002963 NP_002954.2

S100A7 Antibody, PSOR1 Antibody, Psoriasin Antibody, Protein S100-A7 Antibody, Psoriasin 1 Antibody, S100A7c Antibody


Specifications

Target
Human S100A7 / Psoriasin
Host
Goat
Reactivity
Human (tested or 100% immunogen sequence identity)
Predicted
Monkey (at least 90% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Applications
  • IHC
  • IHC - Paraffin (3.75 µg/ml)
  • Western blot (0.1 - 1 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:32000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Immunogen
Synthetic peptide C-HKYTRRDDKIDKP from an internal region of human S100A7 (NP_002954.1). Percent identity by BLAST analysis: Gorilla, Gibbon (100%); Human, Marmoset (92%); Horse (85%).
Blocking Peptide
LS-E26111 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-B4332. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Epitope
aa18-30
Specificity
Human S100A7.
Presentation
Tris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only.
Guarantee
This antibody carries the LSBio 100% Guarantee.

Publications (0)


Customer Reviews (0)


Images


Immunohistochemistry

Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.
Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.

Western blot

HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima
HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima

Western blot

HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.
HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.

Immunohistochemistry

Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.
Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.

Western blot

HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima
HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima

Western blot

HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.
HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.

Immunohistochemistry

Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.
Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.

Western blot

HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima
HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima

Western blot

HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.
HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.

Immunohistochemistry

Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.
Anti-S100A7 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B4332 concentration 3.75 ug/ml.

Western blot

HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima
HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed (1mg/ml) in Lane B. Prima

Western blot

HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.
HEK293 lysate (10 ug protein in RIPA buffer) overexpressing Human S100A7 with C-terminal MYC tag probed with S100A7 antibody (0.5 ug/ml) in Lane A and probed with anti-MYC Tag in Lane C. Mock-transfected HEK293 probed with S100A7 antibody (1 mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.


Requested From: 
Date Requested: 6/24/2018

Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn PSL Alliance Member
Copyright © 2018 LifeSpan BioSciences, Inc. All Rights Reserved Privacy Policy



Catalog Number